Abstract:Aims: This study was conducted to explore the high-intensity focused ultrasound (HIFU) prepared antigen-sensitized dendritic cells (DC) and the induction of cytotoxic T lymphocyte (CTL) killing effects by DC and to observe their anti-tumor immunity effects on BALB/c mice. Methods and material: GM-CSF and IL-4 were used to culture the mouse bone marrow-derived DC. HIFU was used to prepare CT-26 tumor cell antigen-sensitive DC vaccines. The capability of T cell proliferation was detected by 3H-TdR, and the CTL cytotoxicity was detected using standard 4h51Cr release assay. The DC-based tumor vaccine prepared using HIFU irradiation was given to normal BALB/c mice. The mice were injected with CT-26 cancer cells subcutaneously seven days later. Further, the occurrence time of the tumor, its weight and volume on the 20th day was observed, and the allergic DC group challenged using repeated-freezing-thawing method alone with the normal saline control group (negative control group) were used to compare group differences. Results: DC in the HIFU group, tumor cell freeze-thawing group, tumor supernatant group, and phosphate buffer solution (PBS) group could induce T cell proliferation in vitro. However, the ability to induce T cell proliferation of DC in the HIFU group and tumor cell freeze-thawing group was significantly higher than those in the tumor supernatant and PBS groups (P < 0. 05). CTL induced in vitro by DC in the HIFU group, and the tumor cell freeze-thawing group had significant cytotoxicity to colon cancer, being significantly different from those in the tumor supernatant and PBS groups (P < 0.05). There was no significant difference between the cytotoxicity of CTL induced in vitro in the HIFU group and the tumor cell freeze-thawing group (P > 0.05). Additionally, significant differences in the occurrence time of the tumor, its weight and volume on the 20th day, and the median survival time of mice among the HIFU group, the repeated-freezing-thawing group, and the negative control group were observed (P < 0.01 or P < 0.05). There was a significant difference between the HIFU and the repeated-freezing-thawing group (P < 0.05). Conclusions: HIFU prepared antigen-sensitized DC could cause substantial proliferation of T cells and CTL with strong anti-tumor effects. The DC-based tumor vaccine prepared using HIFU irradiation affected active immunization on the tumor occurrence in vitro and was better than the DC-based tumor vaccine prepared using the repeated-freezing-thawing method.

The Experimental Study about the Immunizing Treatment of Prostate Cancer Induced by Sensitized DC

Anti-tumor Response of Dendritic Cells after Pulsed with Whole Tumor Cell Lysates of Prostate Cancer Cell Line

The Immunotherapeutic Effect of Dendritic Cells Vaccine Modified with IFN-γ Inducible Protein-10 Gene and Tumor Cell Lysate on Mice with Prostate Cancer

Induction of Prostate Cancer-Specific CTLs with Dendritic Cells Pulsed by Different Types of Tumor Antigens

Telomerase Pulsed Dendritic Cells Induced Antitumor Immune Response Against Prostate Cancer in Vitro

Experimental Study on the Immune Functions of Splenic Dendritic Cells after a Combined Therapy of Cryoablation and Granulocyte Macrophage-Colony Stimulating Factor for Prostate Cancer

Immune Response Against Prostate Cancer Cells Induced by Recombinant Adenovirus Encoding Truncated Prostate Specific Membrane Antigen Gene and 4-1BBL Gene Modified Dendritic Cells in Vitro

Experimental Study of Treatment of Prostate Cancer with Murine Dendritic Cells Pulsed with Tumor Cell RNA

Antitumor Effects of Ad-PSMA-Pulsed Dendritic Cells Cocultured with Autologous Cytokine-Induced Killer Cells on Prostate Cancer in Vivo

Antitumor Immunity by a Dendritic Cell Vaccine Encoding Secondary Lymphoid Chemokine and Tumor Lysate on Murine Prostate Cancer

Immunotherapeutic effect of dendritic cell vaccine modified with the CXCL10 gene and tumor cell RNA on mice with prostate cancer

Enhanced Function of Cytotoxic T Lymphocytes Induced by Dendritic Cells Modified with Truncated PSMA and 4-1BBL.

Anti-cancer effect of cytotoxic T lymphocytes activated by sensitized dendritic cells

Dendritic Cells Loaded with Prostate Stem Cell Antigen: Preparation of a Prostate Cancer Vaccines Against Prostatic Carcinoma

TGF-β insensitive dendritic cells: an efficient vaccine for murine prostate cancer

The anti-tumor immune response of specific cytotoxic T lymphocytes induced by breast cancer stem cells RNA-DCs vaccine

Immune Effect of Co-Culture of Dendritic Cells and Cytokine-Induced Killer Cells on Prostate Cancer Cells

Experimental Study of Anti-Tumor Immunologic Response Induced by Cryoablation for Prostate Cancer

Research of dendritic cells pulsed with PSA peptide inducing specific CTL in vitro

Experimental study on the induction of cytotoxic T lymphocyte killing effects and dendritic-cell-based tumor vaccine prepared by high-intensity focused ultrasound

Effect of dendritic cells sensitized by tumor cells lysates on the murine breast cancer